Fresenius pulls out of Akorn acquisition

23 April 2018 - Deborah Wilkes

Archived

German healthcare company Fresenius is pulling out of its planned USD4.75 billion acquisition of US generics, OTC and animal health company Akorn.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: